Hira Mian, Hematology Oncologist, Multiple Myeloma Lead at Hamilton Health Sciences, shared a post on X about a paper published in American Journal of Hematology:
“Outcomes of 1477 TIE patients treatment in Canada (n=742 Rd, n=392 VRd, n=343 DRd). DRd outperforms for both TTNT and OS. Hopefully quads getting funded soon. thank you team with Raj Chakraborty, Nadine A, Luciano J Costa, Alissa V, Rafael Fonseca, Shaji Kumar.”
Title: Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study
Authors: Nadine Abdallah, Hira Mian, Hsien Seow, Gregory P. Pond, Anastasia Gayowsky, Alissa Visram, Luciano J. Costa, Tanya M. Wildes, Rafael Fonseca, Charlotte Pawlyn, Gordon Cook, Shaji Kumar, Rajshekhar Chakraborty
Read the full article.
More posts featuring Hira Mian on OncoDaily.